This Week in BMC Cancer | GenomeWeb

This Week in BMC Cancer

Premium

Reporting on behalf of the SYNCHRONOUS trial group, the University of Heidelberg's Jurgen Weitz and his colleagues present the details of their clinical investigation, in which they aim to assess whether "patients with colon cancer and synchronous unresectable metastases who present without severe symptoms should undergo resection of the primary tumor prior to systemic chemotherapy." In BMC Cancer, the researchers say that eligible patients enrolled in their multicenter, randomized, contro

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.